Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 15.0T | 14.3T | 13.9T | 13.3T |
Cost of revenue | 7.2T | 7.1T | 7.8T | 6.9T |
Gross profit | 7.8T | 7.2T | 6.1T | 6.4T |
Operating expense | ||||
Research & development | 1.1T | 1.1T | 1.1T | 996.4B |
Selling general and admin | 1.6T | 1.5T | 1.9T | 1.4T |
Other operating expenses | — | — | — | — |
Operating income | 5.1T | 4.5T | 3.1T | 3.9T |
Non operating interest income | ||||
Income | 53.7B | 69.0B | 73.3B | — |
Expense | 247.6B | 249.6B | 261.1B | 279.9B |
Other income expense | — | — | — | — |
Pretax income | 4.9T | 4.4T | 2.9T | 3.7T |
Tax provision | 686.2B | 438.3B | 360.1B | 460.1B |
Net income | 4.2T | 3.9T | 2.5T | 3.2T |
Basic EPS | 7.4 | 6.8 | 4.4 | 5.5 |
Diluted EPS | 7.2 | 6.6 | 4.3 | 5.4 |
Basic average shares | 576.4B | 579.2B | 579.8B | 580.5B |
Diluted average shares | 589.5B | 592.3B | 593.4B | 593.6B |
EBITDA | 10.5T | 9.9T | 8.9T | 9.1T |
Net income from continuing op. | 4.2T | 3.9T | 2.5T | 3.2T |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |